Biodesix to acquire Oncimmune lab in Marketplace Directory Create PDFBiodesix’s Nodify XL2 test is used to help rule out malignancy in low- to moderate-risk incidental lung nodules. Biodesix, 303-417-0500 Pages: 1 2 Biodesix 2019-10-21 CAP TODAY Previous Post Next Post
CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
